Bayesian Capital Management’s Douglas Emmett DEI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-13,499
Closed -$127K 251
2026
Q1
$127K Buy
13,499
+2,700
+25% +$27.8K 0.16% 126
2025
Q4
$119K Buy
+10,799
New +$135K 0.27% 101
2025
Q2
Sell
-10,400
Closed -$166K 618
2025
Q1
$166K Buy
+10,400
New +$176K 0.03% 510
2024
Q1
Sell
-10,862
Closed -$157K 845
2023
Q4
$157K Buy
+10,862
New +$138K 0.02% 630
2023
Q1
Sell
-13,039
Closed -$204K 863
2022
Q4
$204K Buy
+13,039
New +$217K 0.03% 593
2022
Q3
Sell
-15,719
Closed -$352K 763
2022
Q2
$352K Buy
+15,719
New +$438K 0.07% 426
2016
Q1
Sell
-6,537
Closed -$204K 370
2015
Q4
$204K Buy
+6,537
New +$200K 0.29% 172

Other funds holding DEI

Bayesian Capital Management's DEI Position: Q2 2026 in Review

Bayesian Capital Management sold out of Douglas Emmett (DEI) in Q2 2026, closing a stake of 13,499 shares — an estimated $127K sold.

Bayesian Capital Management first reported a position in DEI in Q4 2015 and held it in 7 quarters. The position peaked at $352K in Q2 2022. 284 funds tracked by Wall St. Rank hold DEI as of Q2 2026.

  • Bayesian Capital Management reported no remaining Douglas Emmett position as of Q2 2026 after selling out during the quarter.
  • Bayesian Capital Management sold 13,499 Douglas Emmett shares in Q2 2026, an estimated $127K.
  • Bayesian Capital Management first reported a position in Douglas Emmett in Q4 2015 and held it in 7 quarters.
  • Bayesian Capital Management's Douglas Emmett position peaked at $352K in Q2 2022.
  • 284 funds tracked by Wall St. Rank held Douglas Emmett as of Q2 2026.

Based on Bayesian Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.